These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 16499817)

  • 1. Diagnostic and prognostic yield of tumor markers in cancer of unknown primary site.
    Parvez T; Ibraheim MI
    J Coll Physicians Surg Pak; 2006 Feb; 16(2):154-6. PubMed ID: 16499817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor markers in metastatic disease from cancer of unknown primary origin.
    Milović M; Popov I; Jelić S
    Med Sci Monit; 2002 Feb; 8(2):MT25-30. PubMed ID: 11859288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of prognosis and surgical indications for pulmonary metastasectomy from colorectal cancer.
    Iizasa T; Suzuki M; Yoshida S; Motohashi S; Yasufuku K; Iyoda A; Shibuya K; Hiroshima K; Nakatani Y; Fujisawa T
    Ann Thorac Surg; 2006 Jul; 82(1):254-60. PubMed ID: 16798225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum tumor markers in skeletal metastasis.
    Tsukushi S; Katagiri H; Kataoka T; Nishida Y; Ishiguro N
    Jpn J Clin Oncol; 2006 Jul; 36(7):439-44. PubMed ID: 16815865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Markers of adenocarcinoma characteristic of the site of origin: development of a diagnostic algorithm.
    Dennis JL; Hvidsten TR; Wit EC; Komorowski J; Bell AK; Downie I; Mooney J; Verbeke C; Bellamy C; Keith WN; Oien KA
    Clin Cancer Res; 2005 May; 11(10):3766-72. PubMed ID: 15897574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case with widespread cutaneous metastases of unknown primary origin: grave prognostic finding in cancer.
    Koca R; Ustundag Y; Kargi E; Numanoglu G; Altinyazar HC
    Dermatol Online J; 2005 Mar; 11(1):16. PubMed ID: 15748557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical value of combined detection of serum tumor markers in lung cancer diagnosis].
    Chen F; Li WM; Wang DM; Gao SS; Bao Y; Chen WB; Liu D
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):832-5. PubMed ID: 19024326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostic difficulties in diffuse pulmonary infiltrations].
    Zielińska-Leś I; Kamiński J; Kozielski J
    Wiad Lek; 2006; 59(9-10):724-6. PubMed ID: 17338139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases.
    Chen C; Chen LQ; Yang GL; Li Y
    Ai Zheng; 2007 Nov; 26(11):1221-6. PubMed ID: 17991322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Progress in the diagnosis of unknown primary neoplasms].
    Nicolosi A; Massidda B; Rais M; Addis E; Tarquini A
    Minerva Chir; 1990 Nov; 45(21-22):1343-6. PubMed ID: 2097558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mediastinal lymph node carcinoma of unknown primary site; report of a case].
    Miura K; Yoshizawa K; Tamaki M; Okumura K; Furukita Y
    Kyobu Geka; 2009 Mar; 62(3):255-7. PubMed ID: 19280962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic value of bone marrow biopsy for bone marrow metastatic tumor with unknown primary tumor site].
    Wu Y; Yao LQ; Cheng J; Tian H
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):1069-71. PubMed ID: 20501396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total procollagen type 1 amino-terminal propeptide (total P1NP) as a bone metastasis marker in gynecological carcinomas.
    Oremek G; Sauer-Eppel H; Klepzig M
    Anticancer Res; 2007; 27(4A):1961-2. PubMed ID: 17649805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Unknown primary tumour--diagnostic strategies and treatment].
    Møller AK; Gundgaard MG; Petersen BL; Daugaard G
    Ugeskr Laeger; 2008 Nov; 170(48):3946-9. PubMed ID: 19087733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and treatment in metastatic adenocarcinoma of unknown primary tumour.
    Taal BG; Veenhof CH; Blijham GH; Neijt JP
    Neth J Med; 1988 Apr; 32(3-4):204-11. PubMed ID: 3283582
    [No Abstract]   [Full Text] [Related]  

  • 16. Diagnostic strategies for unknown primary cancer.
    Varadhachary GR; Abbruzzese JL; Lenzi R
    Cancer; 2004 May; 100(9):1776-85. PubMed ID: 15112256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinoma of unknown primary (CUP); some considerations about pathogenesis and diagnostic strategy, particularly focusing on CUPS pertaining to the Urology.
    Alberti C
    G Chir; 2012; 33(1-2):41-6. PubMed ID: 22357439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathological fracture of the ala of the ilium as the form of presentation of an adenocarcinoma of unknown origin].
    Iglesias D; Alegre J; Jufresa J; Fernández de Sevilla T
    An Med Interna; 1999 Jan; 16(1):55. PubMed ID: 10089663
    [No Abstract]   [Full Text] [Related]  

  • 19. Pretreatment serum level of HER2/nue as a prognostic factor in metastatic prostate cancer patients about to undergo endocrine therapy.
    Okegawa T; Kinjo M; Nutahara K; Higashihara E
    Int J Urol; 2006 Sep; 13(9):1197-201. PubMed ID: 16984552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Women with undiagnosed colorectal adenocarcinomas presenting with ovarian metastases: clinicopathologic features and comparison with women having known colorectal adenocarcinomas and ovarian involvement.
    Judson K; McCormick C; Vang R; Yemelyanova AV; Wu LS; Bristow RE; Ronnett BM
    Int J Gynecol Pathol; 2008 Apr; 27(2):182-90. PubMed ID: 18317225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.